Cuff Pressure Control and Evacuation of Subglottic Secretions To Prevent Pneumonia
Key facts
- Who runs it
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Where
- Israel and Italy11 sites in 2 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 270 people enrolled
- Started
- 6 Jun 2022
- Ended
- 9 Apr 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Continuous cuff pressure regulation
- Intermittent cuff pressure regulation
- Automatic subglottic secretion drainage
- Manual subglottic secretion drainage
- Tracheobronchial colonization assessment
- Microaspiration assessment
- VAP assessment
- Record updated
- 7 May 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Primary intubation with the study ETT
- Expected duration of mechanical ventilation >48 hours
- Age older than 18 years
Who cannot take part
- Invasive mechanical ventilation in the last 14 days,
- Contraindication for enteral feeding
- Clinical evidence of inhalation before intubation
- Pregnancy
- Enrolling in another study that may interfere with this trial
This trial has no sites in United States.
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
Multicenter, cluster randomized, controlled, open-label trial to assess if AnapnoGuard System can minimize tracheal microaspiration and the risk of ventilator-associated pneumonia when compared to standard treatment
The 2 groups in the trial
- AnapnoGuard groupTreatment being tested
Patients intubated with AnapnoGuard endotracheal tube (polyvinylchloride tube with ellipsoidal shape, thin wall polyurethane cuff with dual suction lines and an extra venting line) which is connected to AnapnoGuard 100 System
Treatment: Continuous cuff pressure regulation, Automatic subglottic secretion drainage, Tracheobronchial colonization assessment, Microaspiration assessment, and VAP assessment
- Control groupExisting treatment, for comparison
Patients intubated with TaperGuard Evac endotracheal tube (polyvinylchloride conic cuff with additional lumen for subglottic secretion suctioning)
Treatment: Intermittent cuff pressure regulation, Manual subglottic secretion drainage, Tracheobronchial colonization assessment, Microaspiration assessment, and VAP assessment
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- An Innovative Cuff Pressure Control and Evacuation of Subglottic Secretions To Prevent Pneumonia. A Multicenter Cluster-Randomized Trial
- Record updated
- 7 May 2024